The future of the global brachytherapy accessory market looks promising with opportunities in the prostate cancer and gynecological cancer markets.
- Within the type category, brachytherapy needles is expected to witness higher growth over the forecast period due to new designs for brachytherapy needles have better dose delivery.
- Within the application category, prostate cancer is expected to witness higher growth over the forecast period due to new cases of prostate cancer are increasing, creating more demand for brachytherapy.
- In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the increasing rate of cancer cases, combined with the development of new radiotherapy equipment, should broaden the growth potential for brachytherapy.
Emerging Trends in Brachytherapy Accessory Market
There will be growing demand for image-guided, automated, integrated brachytherapy solutions as cancer centres aim to reduce the procedural time and ensure repetitive accuracy for brachytherapy accessory placements. Lucintel’s analysis reflects the longer-term trends in the market for precision radiation therapy.- Sustainability: In 2025, both European and international procurement Directives increased the focus on end-of-life and life-cycle analysis of medical devices, and harmful materials in devices. Environmentally-conscious evaluations of medical device components will influence the purchase decisions.
- Digital Manufacturing: In 2025, the Radiation Therapy suppliers that adapted Digital Product Development and Digital Planning gained the ability to produce patient-specific therapy solutions. The focus will be on the design and manufacturing of devices to accomplish positioning and verification in therapy.
- Automation: Automated accessories to support image position verification and registration will be adopted by therapy centers to improve procedure times. Further automation in therapy will be adopted to ensure therapeutic procedures are performed by less-trained staff.
- Smart Materials: Flexible polymers, including those that maintain their shape and are detectable in CT and MRI scans, are being developed and commercialized. Recent specification releases have highlighted the importance of CT/MRI visibility for applicators. In the next 5 years, the applicator material used may affect the accuracy of the placement of the dose-delivering components.
- Diversification of Supplier Networks: There is an effort to identify secondary supplier networks for specialized applicators and other sterile disposable accessories. There has been significant volatility in the international transportation of medical devices. If a manufacturer begins to produce devices locally, there may be an improvement in the lead time and availability of those devices.
Recent Developments in the Brachytherapy Accessory Market
The brachytherapy accessory market is showing signs of growth for the 2025-2027 period as hospitals replace outdated brachytherapy applicators and increase image-guided brachytherapy procedures. Also, many hospitals standardize the use of disposable brachytherapy kits. Capital projects dedicated to the construction of new cancer treatment centers provide a further boost to the brachytherapy market. When deciding on equipment purchases, it is expected that the evidence supporting infection control and the equipment’s effect on overall workflow will take center stage.- New Image-guided Brachytherapy Equipment: In 2025, Elekta reported over 120 countries had adopted their advanced brachytherapy equipment (may 2025 report). As new equipment is adopted, hospitals will also purchase new brachytherapy applicators and equipment that will support and integrate the new workflow.
- Increased Investment in Hospital-based Cancer Care: In 2025, the Indian government also approved 22 new cancer care projects (march 2025) as part of its national health infrastructure project. As new radiotherapy equipment and facilities are constructed, new equipment and brachytherapy catheters will also be purchased.
- Greater Use of Disposable Equipment: Disposable brachytherapy equipment also became more prevalent in 2025 due to greater focus on infection control.
- Local Manufacturing: Supply-chain disruptions during 2025 encouraged medical device manufacturers in the Asia-Pacific region to develop more local production. In the near term, the local production of medical devices will shorten the lead time and price-sensitive medical devices. Continued investment to build local production will grow and build stronger supply chains. The medical devices that provide the best overall value will gain market share. Commodity devices will see price erosion and higher-end devices will see improved market opportunities.
- Integration with Work-flow Systems: More radiotherapy vendors' software supported DICOM-based communication in 2025. Over the next several years, the ability to exchange treatment planning information with other systems will drive the purchase of radiation treatment devices.
Strategic Growth Opportunities in the Brachytherapy Accessory Market
The market for brachytherapy accessories is maturing. Cancer treatment facilities have shown interest in brachytherapy devices to treat cancer via an outpatient procedure. They have also shown interest in brachytherapy devices that minimize staff and facility burden. The investment of health care facilities in brachytherapy devices is expected to increase in the 2024-2026 period. Additionally, the incidences of prostate and cervical cancer are expected to increase, creating additional demand for brachytherapy devices. In the coming years, improvements in supplier offerings are expected to increase the overall efficiency, safety, and consistency of the brachytherapy devices.- Image-guided Brachytherapy Applicators: Newer versions of brachytherapy applicators used to be the focus of applicator manufacturing; however, in recent years the focus has been on designing applicators to facilitate image guidance. MRI and CT compatible brachytherapy applicators are expected to gain greater market share in the coming years.
- Outpatient Procedural Kits: Outpatient surgical procedures have increased in the last few years. The kits utilized in outpatient procedures are designed to decrease staff burden and increase consistency. There is potential for the manufacturers of brachytherapy accessories to increase revenue by producing single use kits for outpatient procedures.
- Accessories for Emerging Markets: Inexpensive accessory packages, based upon local financial constraints, could enhance brachytherapy services throughout the Middle East, Latin America and South East Asia. The IAEA’s cancer control projects have assisted more than 50 countries to establish radiotherapy services. It is expected that the distribution of brachytherapy accessories will be achieved by local companies within the next 5 years.
- High-Performance Biomedical Materials: Antimicrobial, radiopaque biocompatible materials could be beneficial to improve infection control in situations where repeated surgical interventions are required. In February 2025, the FDA reported 6,000 medical device recalls. Incorporation of improved materials could enhance the competitiveness of medical devices.
- Procedure Analytical Software: Suppliers of medical devices can integrate software to provide additional services including planning, documentation and inventory control. Cybersecurity incidents occurred in 2015 at 300 or more medical facilities throughout the world. The use of software to plan and document treatment will allow suppliers of medical devices to become retained service providers.
Brachytherapy Accessory Market Drivers and Challenges
Brachytherapy market expansion is synonymous with advancements in the field of oncology, availability of healthcare investment, reimbursement policies, and consenting regulations. More stringent regulations require the use of brachytherapy in place of other, potentially more harmful, therapies. Over the years, several manufacturers have invested in research and development of specialized brachytherapy products and services. While costs, availability, and affordability remain bottlenecks to widespread acceptance of brachytherapy, competing products and services are expected to shape the market, at least in the near term.The factors responsible for driving this market include:
- Increased Product Offerings: Improved accessibility, functionality, and integration with imaging and treatment planning software have led to more widespread adoption of brachytherapy. Additionally, the use of robotics has improved placement and dose delivery. In 2025, numerous cancer centers across the U.S. initiated the use of imaging-brachytherapy to further integrate the use of brachytherapy in oncologic practice. It is expected that in the next few years, integration of various fields of imaging, particularly MRI, with brachytherapy would help reduce the incidence of adverse effects of treatment.
- Rising Demand for Brachytherapy Equipment: The incidence of cervical, prostate, and breast cancers, as well as skin cancers, is on the rise. The International Agency for Research on Cancer estimates there were approximately 20 million new cancer cases in 2022. As the need for cancer treatment is growing, so is the need for equipment to treat cancer. The aging population, along with improvements in medical diagnosis, is expected to result in a growing need for radiation therapy services in the next few years.
- Improving Regulations and Clinical Practices: Manufacturers of brachytherapy equipment can have more confidence in the equipment they manufacture as various regulatory and clinical organizations have issued recommendations and standards for brachytherapy equipment. In the next few years, it is expected that equipment manufacturers will produce equipment in accordance with new standards and recommendations, thereby improving the access and use of brachytherapy equipment.
- Sustainability and Design: The equipment used to deliver radiation therapy is often bulky and not environmentally friendly. In recent years, there has been an increased emphasis on the sustainability of equipment used to treat cancer, and radiation oncology equipment in particular. Manufacturers of radiation therapy equipment will be motivated to redesign equipment to decrease the amount of packaging and to use more sustainable materials in equipment.
- Manufacturing Advances: Precision and modular manufacturing, combined with advanced supply-chain management, has led to significant decreases in the time required to manufacture products, as well as reductions in variability in manufacturer’s production processes. Investments in additive manufacturing, especially in the medical device market, have continued to increase. Prototypes are currently being produced in less than a month. It is expected that within the next three to five years, further reductions in the cost of manufacturing, along with advances in the design and production of patient-specific medical devices, will improve access to medical care in high-risk, high-reward markets.
The challenges facing this market include:
- Costs of Equipment and Procedures: The high costs of equipment and the continuing expense of trained personnel to operate the equipment and perform the procedures necessary in brachytherapy create an economically unattractive market. In addition, pressure on government budgets has led to reduced reimbursements to health care facilities for medical devices. This has led to extended periods between equipment replacements. Equipment costs and capital restrictions will likely continue to be barriers to entry for lower-income markets during the forecast period.
- Limited Workforce: The safe and effective use of brachytherapy requires a multidisciplinary team. Workforce training programs have been developed to help alleviate shortages. During the forecast period, variance in the availability of workforce training, along with a general shortage of health care personnel in rural and remote areas will likely create barriers to the adoption of medical technologies, including advanced medical brachytherapy devices.
- Regulatory and Supply Chain Complexities: The Medical Device industry is constrained by a host of validations (i.e. sterilization, cybersecurity, and documentation) and approvals (i.e. country-specific). In 2025, challenges persisted for Medical Device companies to gain access to required expertise and resource to manufacture specialized products. It is expected that combination of unreliable supplier networks and turbulent regulation will cause substantial disruption in the Medical Device industry within the forecast period.
List of Brachytherapy Accessory Market Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies brachytherapy accessory market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.Some of the brachytherapy accessory market companies profiled in this report include:
- BD
- Argon Medical
- BARD
- Best Medical
- Eckert & Ziegler
- Elekta
- IsoAid
- GE Healthcare
- Riverpoint Medical
- Team Best
Brachytherapy Accessory Market by Segment
The study includes a forecast for the global brachytherapy accessory market by type, application, and region.Type [Value ($M) from 2019 to 2035]:
- Brachytherapy Needles
- Brachytherapy Seeds
- Others
Application [Value ($M) from 2019 to 2035]:
- Prostate Cancer
- Gynecological Cancer
- Others
Region [Value ($M) from 2019 to 2035]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the Brachytherapy Accessory Market
The market is trending with the increase in investments by hospitals for capital equipment, more stringent regulations and the increasing reliance on image-guided procedures. Between 2025 and 2027, expect closer integration of the components of brachytherapy. In the, annual, report dated January 2025, Lucintel asserts that procurement is largely influenced by the capital allocation processes for oncology.- United States: Activities by Elekta in 2025 focused on the further integration of Flexitron with brachytherapy treatment planning and delivery. Varian continued to commercialize its brachytherapy system consisting of the Bravos applicators and accessories. The 2025 Framework for Medical Devices and the National Cancer Program, comprising over 1,500 accredited centres, are creating an environment where the accessory and sub-system level replacements will gain preference (January 2025).
- China: The National Health Commission (NHC) of China released its 2025 action plan for the control and prevention of cancer. During the same period, various manufacturers of medical devices applied to the Chinese Food and Drug Administration (CFDA) for marketing approvals. According to the NHC estimates, the number of new cancer cases in 2022 was 4.8 million. The recently awarded tenders will construct new radiotherapy centers. The new centers along with other recently awarded tenders will increase demand for consumables, which are needed for the operation of radiotherapy machines.
- Germany: The Federal government will invest €4.3 billion (USD 4.6 billion) for the renovation and expansion of hospitals. From 2025, German hospitals will have the opportunity to receive federal funds to invest in advanced diagnostic and cancer treatment centers. German hospitals will invest in facilities to provide advanced radiotherapy, including image-guided radiotherapy. Such investments will increase the demand for imaging systems, positioning devices and other accessories.
- India: As part of the 2025 union budget, the Indian government allocated INR 983 billion (USD 12.6 billion) to the Indian Ministry of Health and Family Welfare. The government allocated additional funds for establishment of oncology units in India. In the next 3-5 years, new radiotherapy centers will be established in India. The government will fund the establishment of oncology centers in the public and private sectors.
- Japan: Funds were released for the establishment of new advanced oncology units in Japan. The Japanese government, in its 2025 Estimates, set aside funds for advancement of cancer treatment. The number of new cases of cancer in Japan was estimated at 1,230,000 in 2025. In 2025, a new reimbursement policy was announced for advanced cancer treatment.
Features of the Global Brachytherapy Accessory Market
- Market Size Estimates: brachytherapy accessory market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
- Segmentation Analysis: brachytherapy accessory market size by type, application, and region in terms of value ($B).
- Regional Analysis: brachytherapy accessory market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the brachytherapy accessory market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brachytherapy accessory market.- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the brachytherapy accessory market by type (brachytherapy needles, brachytherapy seeds, and others), application (prostate cancer, gynecological cancer, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- BD
- Argon Medical
- BARD
- Best Medical
- Eckert & Ziegler
- Elekta
- IsoAid
- GE Healthcare
- Riverpoint Medical
- Team Best
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

LOADING...

